
April 24, 2023
RegMed Investors’ (RMi) closing bell: calling the ball on underperforming share pricing, just too many factors to list
April 24, 2023
RegMed Investors’ (RMi) pre-open: the push-pull of April’s share pricing facilitates more uncertainty in the short-term
April 21, 2023
RegMed Investors’ (RMi) closing bell: the oversold cell and gene therapy sector was feeling the love
April 21, 2023
RegMed Investors’ (RMi) pre-open: begging for sector upside with a sidewalk situated tin can
April 20, 2023
RegMed Investors’ (RMi) closing bell: the percentage downsizers are telling
April 20, 2023
RegMed Investors’ (RMi) pre-open: how long will trimming losses last?
April 19, 2023
RegMed Investors’ (RMi) closing bell: algorithms recognized the oversold
April 19, 2023
RegMed Investors’ (RMi) pre-open: recessionary fear is stealing from the upside
April 18, 2023
RegMed Investors’ (RMi) pre-open: support stimulates sustainability as I continue heightened analysis
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors